100 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
clinical trials may begin; approval by an independent institutional review board, or IRB, for each clinical site or centrally before each trial may … development, as well as amendments to previously submitted clinical trials. Further, an independent IRB for each institution participating in the clinical trial
8-K
CCCC
C4 Therapeutics Inc
8 Mar 24
Departure of Directors or Certain Officers
4:10pm
alternatives, and a review of other applicable factors with the input of the Committee’s independent compensation consultant. The Committee designed
S-8
445ly5tctl
22 Feb 24
Registration of securities for employees
9:01am
S-8
EX-5.1
4u43sbq8vi8m8
22 Feb 24
Registration of securities for employees
9:01am
S-8
EX-23.2
fa5pivbj9
22 Feb 24
Registration of securities for employees
9:01am
8-K
EX-99.1
l3od0zi hde0g4k1kgl
20 Nov 23
C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment
7:05am
8-K
ms9m4d ij
20 Jun 23
C4 Therapeutics Appoints Leonard Reyno, M.D., as Chief Medical Officer
7:11am
8-K
EX-10.2
vr2c72 ikgtnn067
30 May 23
Entry into a Material Definitive Agreement
7:30am
8-K
EX-10.1
he40csa 38
30 May 23
Entry into a Material Definitive Agreement
7:30am
8-K
EX-99.1
lbaerier1s uh7824o0b
30 May 23
Entry into a Material Definitive Agreement
7:30am
ARS
mjjy0z f9c5fsakr5if8
28 Apr 23
Annual report to shareholders
7:03am